Revenue: The sum of all revenue fields included for a company's operating activities.
ADARx Pharmaceuticals, Inc. (ADRX) had Revenue of $2.22M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
|
Revenue |
$2.22M |
$-28.12M |
|
-- |
|
$2.22M |
|
$34.39M |
|
$-32.18M |
|
$4.06M |
|
$-28.12M |
|
$-28.12M |
|
$-28.12M |
|
$-28.12M |
|
$-28.12M |
|
$-28.12M |
|
$-32.18M |
|
$-32.18M |
|
16.13M |
|
16.13M |
|
$-1.74 |
|
$-1.74 |
|
| Balance Sheet Financials | |
$918.51M |
|
$4.40M |
|
$10.55M |
|
$929.06M |
|
$43.57M |
|
-- |
|
$311.09M |
|
$354.66M |
|
$574.40M |
|
$574.40M |
|
$574.40M |
|
107.26M |
|
| Cash Flow Statement Financials | |
$-76.75M |
|
$78.61M |
|
$502.10M |
|
$66.52M |
|
$570.61M |
|
$504.09M |
|
$4.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
21.08 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1451.38% |
|
-1451.38% |
|
-- |
|
-1268.24% |
|
-1268.24% |
|
$-77.39M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-4.89% |
|
-4.89% |
|
-3.03% |
|
-4.89% |
|
$5.36 |
|
$-4.80 |
|
$-4.76 |
|